GlycoVaxyn

American currency next to a clock
Biotech

Big Pharma-backed GlycoEra raises $130M for protein degraders

The cash will primarily go toward initiating clinical trials for GE8820, a bispecific molecule designed to destroy IgG4 autoantibodies.
Darren Incorvaia May 27, 2025 7:00am
unlabeled vaccine

LimmaTech regains shigella shot from GSK, new CEO from CureVac

Jul 20, 2023 10:31am
A person holds out a bag of money

Veterans from GSK's GlycoVaxyn rally up $49M for new biotech

Nov 5, 2021 6:00am